The Effect of TUBER Recommendations and the DASH Diet on Blood Parameters in Patients With Gestational Diabetes
1 other identifier
interventional
38
1 country
1
Brief Summary
The aim of this clinical trial was to examine the effects of the Turkish Nutrition Guide Recommendations Diet and the DASH Diet on blood sugar, blood pressure, and biochemical parameters in patients with gestational diabetes. The study hypotheses are as follows: Hypothesis 1: The DASH diet reduces fasting blood glucose levels more in patients with gestational diabetes compared to a diet adapted to a healthy diet specific to Türkiye. Hypothesis 1: The DASH diet reduces insulin levels more in patients with gestational diabetes compared to a diet adapted to a healthy diet specific to Turkey. Hypothesis 1: The DASH diet reduces HbA1c levels more in patients with gestational diabetes compared to a diet adapted to a healthy diet specific to Türkiye. Hypothesis 1: The Dash diet reduces 1st-hour postprandial glucose levels more significantly in women with gestational diabetes compared to a diet adapted to a healthy diet typical of Türkiye. Participants: After being diagnosed with gestational diabetes by a doctor using an OGTT test at 24-28 weeks, the researcher will complete a general information form during their first consultation with the dietitian. For four weeks, the dietitian will follow the diets created by the researcher based on their assigned diet group in a blinded manner. They will record their fasting and postprandial blood sugar levels in the morning, noon, evening, night, and during snacks, if they are taking them. They will keep a 24-hour food consumption record before meeting with the researcher weekly. Participants will have their biochemical parameters assessed at the beginning of the study and at the end of the fourth week.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 22, 2025
CompletedFirst Submitted
Initial submission to the registry
July 24, 2025
CompletedFirst Posted
Study publicly available on registry
August 3, 2025
CompletedAugust 7, 2025
August 1, 2025
12 months
July 24, 2025
August 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in fasting blood glucose levels
To monitor daily fasting blood glucose levels (mg/dL) using a glucometer throughout the 4-week intervention.
Daily for 4 weeks
Secondary Outcomes (7)
Change in 1-hour postprandial blood glucose levels
Daily for 4 weeks
Change in fasting insulin level
Baseline and Week 4
Change in daily energy and nutrient intake based on 24-Hour Food Consumption Record
Baseline and weekly over 4 weeks
Change in lipid profile (total cholesterol, HDL-C, LDL-C, triglycerides)
Baseline and Week 4
Change in iron-related parameters (iron, ferritin, total iron-binding capacity)
Baseline and Week 4
- +2 more secondary outcomes
Study Arms (2)
Active Comparator: Türkiye Nutrition Guideline Diet Group
ACTIVE COMPARATORParticipants followed a diet based on the Türkiye Nutrition Guideline (TÜBER) for pregnancy. The diet consisted of 45-60% carbohydrates, 12-20% protein (minimum 70 g), and 20-35% fat. Portion sizes were explained during the initial consultation. Participants recorded their food intake weekly and attended weekly follow-up visits for anthropometric and blood pressure measurements. Diets were adjusted weekly based on blood glucose levels.
Active Comparator: DASH Diet Group
ACTIVE COMPARATORParticipants followed a diet based on the Dietary Approaches to Stop Hypertension (DASH) guidelines. The diet consisted of 45-60% carbohydrates (minimum 175 g), 12-20% protein (minimum 70 g), and 20-35% fat including 6% saturated fat and 150 mg cholesterol. It was low in sodium (2300 mg/day) and rich in potassium (4700 mg), calcium (1250 mg), and magnesium (500 mg). It emphasized low-fat dairy, lean meats, 10 servings/day of fruits and vegetables, and 4-5 servings/week of nuts, seeds, and legumes. Weekly follow-ups were conducted as in the other group.
Interventions
A diet structured according to the Türkiye Nutrition Guideline (TÜBER) for pregnant women, consisting of 45-60% carbohydrates, 12-20% protein (minimum 70 g), and 20-35% fat. Diets were tailored weekly based on blood glucose levels and individual dietary intake records.
A dietary plan based on DASH guidelines: 45-60% carbohydrates (≥175 g), 12-20% protein (≥70 g), 20-35% fat (≤6% saturated), ≤2300 mg sodium, ≥4700 mg potassium, ≥1250 mg calcium, ≥500 mg magnesium. Includes low-fat dairy, lean meats, fruits/vegetables, and nuts/seeds.
Eligibility Criteria
You may qualify if:
- Female participants aged 18 to 35 years
- Singleton pregnancy
- Clinical diagnosis of gestational diabetes mellitus (GDM)
- Ability to use a glucometer
You may not qualify if:
- Pre-gestational diabetes or impaired glucose tolerance (IGT)
- Hypoglycemia
- Receiving insulin therapy
- Development of preeclampsia
- Failure to adhere to the prescribed diet
- Smoking
- Alcohol consumption
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Atlas Univercity Hospital
Istanbul, Bagcılar, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Research Asisstant (Dietitian)
Study Record Dates
First Submitted
July 24, 2025
First Posted
August 3, 2025
Study Start
June 1, 2024
Primary Completion
May 20, 2025
Study Completion
July 22, 2025
Last Updated
August 7, 2025
Record last verified: 2025-08